Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register
- Paolicelli, Damiano
- Lucisano, Giuseppe
- Manni, Alessia
- Avolio, Carlo
- Bonavita, Simona
- Brescia Morra, Vincenzo
- Capobianco, Marco
- Cocco, Eleonora
- Conte, Antonella
- De Luca, Giovanna
- De Robertis, Francesca
- Gasperini, Claudio
- Gatto, Maurizia
- Gazzola, Paola
- Lus, Giacomo
- Iaffaldano, Antonio
- Iaffaldano, Pietro
- Maimone, Davide
- Mallucci, Giulia
- Maniscalco, Giorgia T
- Marfia, Girolama A
- Patti, Francesco
- Pesci, Ilaria
- Pozzilli, Carlo
- Rovaris, Marco
- Salemi, Giuseppe
- Salvetti, Marco
- Spitaleri, Daniele
- Totaro, Rocco
- Zaffaroni, Mauro
- Comi, Giancarlo
- Amato, Maria Pia
- Trojano, Maria
Publication date
September 2019
DOIAbstract
The increase in disease-modifying drugs (DMDs) allows individualization of treatment in relapsing multiple sclerosis (RMS); however, the long-term impact of different treatment sequences is not well established. This is particularly relevant for MS patients who may need to postpone more aggressive DMD strategies
Add to ORKG